Altimmune (ALT) Stocktwits Mentions Statistics 2025

859 3.5%

1W 24.1% 1M 32.6% 3M 38.5%

Est. daily mentions on Stocktwits.

Similar companies

Company		Stocktwits Mentions
	Amgen AMGN	18 21.7%
	Gilead Sciences GILD	111 146.7%
	Catalyst Pharmaceuticals CPRX	11 57.1%
	Inovio Pharmaceuticals INO	241 4%
	Anavex Life Sciences AVXL	282 8%

Month over Month

Est. daily mentions on Stocktwits.

Mar 2025	2,004	73.5%
Feb 2025	1,155	29.6%
Jan 2025	1,642	10.7%
Dec 2024	1,838	5.6%
Nov 2024	1,741

How often is Altimmune mentioned on StockTwits?

Altimmune was mentioned an estimated 859 times in discussions on StockTwits yesterday.

Analyzing Stocktwits Mentions, how is Altimmune performing compared to its industry peers?

Altimmune overperforms a majority of its industry peers when it comes to Stocktwits Mentions, ranking in the 91st percentile.

What does a high frequency of StockTwits mentions indicate for Altimmune's market sentiment?

A high frequency of mentions on StockTwits for Altimmune could indicate strong market interest or sentiment towards the company. It often reflects the trading community's engagement with Altimmune's stock, potentially signaling bullish or bearish trends based on the context of the discussions.

How often does AltIndex update information on Altimmune's mentions on StockTwits?

AltIndex updates the data on Altimmune's mentions on StockTwits daily. This frequent update schedule ensures that investors have access to the most current insights into market sentiment and discussion dynamics related to Altimmune's on the platform.

About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.